Actively Recruiting

Phase 3
Age: 1Day - 18Years
All Genders
NCT07019922

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

Led by Praxis Precision Medicines · Updated on 2026-05-13

50

Participants Needed

4

Research Sites

172 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A Randomized, Multi-Center, Double-Blind, Sham-Procedure-Controlled Clinical Trial to Investigate the Efficacy and Safety of Elsunersen in Pediatric Participants with Early Onset SCN2A Developmental and Epileptic Encephalopathy

CONDITIONS

Official Title

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

Who Can Participate

Age: 1Day - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Has a documented Gain of Function SCN2A variant confirmed through genetic testing.
  • Has onset of seizures prior to 3 months of age.
  • Seizure frequency of 4 or more countable motor seizures per 28-day during the Baseline Observation Period.
Not Eligible

You will not qualify if you...

  • Has any clinically significant or known pathogenic genetic variant other than in the SCN2A gene, or a genetic variant that may explain or contribute to the participant's epilepsy and/or developmental disorder.
  • Has bone, spine (eg, kyphosis, scoliosis), bleeding, or other disorder.
  • Has received any experimental or investigational drug, device, or other therapy within 30 days or 5 half-lives (whichever is longer) prior to Screening, including any prior use of gene therapy.
  • Is currently pregnant or breastfeeding or is planning to become pregnant during the clinical trial.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Praxis Research Site

San Diego, California, United States, 92123

Actively Recruiting

2

Praxis Research Site

Chicago, Illinois, United States, 60612

Actively Recruiting

3

Praxis Research Site

Porto Alegre, Brazil, 90035

Actively Recruiting

4

Praxis Research Site

São Paulo, Brazil, 05403

Actively Recruiting

Loading map...

Research Team

H

Head of Pharmacovigilance

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety | DecenTrialz